Paper41004020
Exploring the Activity of Bacteriocins Against Bacterial Biofilms Using a Simple and Inexpensive Assay.
Fernández M and 6 others. Probiotics Antimicrob Proteins, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Exploring the Activity of Bacteriocins Against Bacterial Biofilms Using a Simple and Inexpensive Assay. Papers, record 41004020. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41004020
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring the Activity of Bacteriocins Against Bacterial Biofilms Using a Simple and Inexpensive Assay.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biofilms | Major topic |
| Bacteriocins | Major topic |
| Anti-Bacterial Agents | Major topic |
| Gram-Positive Bacteria | Major topic |
| Gram-Negative Bacteria | Major topic |
| Microbial Sensitivity Tests | |
| Nisin |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P20_00339 | Proyectos de I+D+i del Plan Andaluz de Investigación, Desarrollo e Innovación | PubMed | ||
| B-BIO-268-UGR20 | Programa Operativo FEDER 2020 | PubMed | ||
| C-EXP-163-UGR23 | Programa Operativo FEDER 2021-2027 | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16973881 | An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. | Science | 2006 | https://conductscience.org/library/papers/16973881 | PubMed |
| 2 | 38730101 | Bacteriocin diversity, function, discovery and application as antimicrobials. | Nat Rev Microbiol | 2024 | https://conductscience.org/library/papers/38730101 | PubMed |
| 3 | 24025153 | Limitations of MIC as the sole criterion in antimicrobial drug dosage regimen design: the need for full characterization of antimicrobial pharmacodynamic profile especially for drug-resistant organisms. | Vet J | 2013 | https://conductscience.org/library/papers/24025153 | PubMed |
| 4 | 14607403 | A simple method for semi-preparative-scale production and recovery of enterocin AS-48 derived from Enterococcus faecalis subsp. liquefaciens A-48-32. | J Microbiol Methods | 2003 | https://conductscience.org/library/papers/14607403 | PubMed |
| 5 | 36879323 | Customized biofilm device for antibiofilm and antibacterial screening of newly developed nanostructured silver and zinc coatings. | J Biol Eng | 2023 | https://conductscience.org/library/papers/36879323 | PubMed |
| 6 | 19291402 | Modeling growth and quorum sensing in biofilms grown in microfluidic chambers. | Ann Biomed Eng | 2009 | https://conductscience.org/library/papers/19291402 | PubMed |
| 7 | 33006097 | Bacteriocin-a potential antimicrobial peptide towards disrupting and preventing biofilm formation in the clinical and environmental locales. | Environ Sci Pollut Res Int | 2020 | https://conductscience.org/library/papers/33006097 | PubMed |
| 8 | 34419547 | Antibacterial directed chemotherapy using AS-48 peptide immobilized on biomimetic magnetic nanoparticles combined with magnetic hyperthermia. | Int J Biol Macromol | 2021 | https://conductscience.org/library/papers/34419547 | PubMed |
| 9 | 21590312 | AS-48 bacteriocin: close to perfection. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/21590312 | PubMed |
| 10 | 35115704 | Tolerance and resistance of microbial biofilms. | Nat Rev Microbiol | 2022 | https://conductscience.org/library/papers/35115704 | PubMed |
| 11 | 22212072 | Pseudomonas biofilm matrix composition and niche biology. | FEMS Microbiol Rev | 2012 | https://conductscience.org/library/papers/22212072 | PubMed |
| 12 | 18274517 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. | Nat Protoc | 2008 | https://conductscience.org/library/papers/18274517 | PubMed |
| 13 | 11168186 | EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. | Clin Microbiol Infect | 2000 | https://conductscience.org/library/papers/11168186 | PubMed |
| 14 | 20457816 | Spatial and temporal patterns of biocide action against Staphylococcus epidermidis biofilms. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20457816 | PubMed |
| 15 | 23558192 | Combined treatments of enterocin AS-48 with biocides to improve the inactivation of methicillin-sensitive and methicillin-resistant Staphylococcus aureus planktonic and sessile cells. | Int J Food Microbiol | 2013 | https://conductscience.org/library/papers/23558192 | PubMed |
| 16 | 31088602 | Nisin penetration and efficacy against Staphylococcus aureus biofilms under continuous-flow conditions. | Microbiology (Reading) | 2019 | https://conductscience.org/library/papers/31088602 | PubMed |
| 17 | 23070152 | In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/23070152 | PubMed |
| 18 | 34438974 | Antimicrobial Activity of the Circular Bacteriocin AS-48 against Clinical Multidrug-Resistant Staphylococcus aureus. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34438974 | PubMed |
| 19 | 17218029 | A new device for rapid evaluation of biofilm formation potential by bacteria. | J Microbiol Methods | 2007 | https://conductscience.org/library/papers/17218029 | PubMed |
| 20 | 36819031 | Advances in the preclinical characterization of the antimicrobial peptide AS-48. | Front Microbiol | 2023 | https://conductscience.org/library/papers/36819031 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41004020
GET https://conductscience.org/api/papers/v1/41004020/references?page=2